Brandes Investment Partners »

Eagle Pharmaceuticals shares owned by Brandes Investment Partners

Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by Brandes Investment Partners from 13F filings

Historical chart of Brandes Investment Partners investment in Eagle Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eagle Pharmaceuticals held by Brandes Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eagle Pharmaceuticals by Brandes Investment Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.9M 745k 5.23
2023-09-30 $18M 1.1M 15.77
2023-06-30 $16M 841k 19.44
2023-03-31 $16M 545k 28.37
2022-12-31 $12M 416k 29.23
2022-09-30 $12M 468k 26.42
2022-06-30 $21M 464k 44.43
2022-03-31 $21M 432k 49.49
2021-12-31 $31M 614k 50.92
2021-09-30 $38M 673k 55.78
2021-06-30 $31M 717k 42.80
2021-03-31 $20M 490k 41.06
2020-12-31 $12M 264k 46.50
2020-09-30 $6.6M 155k 42.50
2020-06-30 $340k 7.1k 47.95
2020-03-31 $6.9M 151k 46.00
2019-12-31 $312k 5.2k 60.14
2019-09-30 $290k 5.1k 56.52
2019-06-30 $412k 7.4k 55.73
2019-03-31 $1.1M 22k 50.51
2018-12-31 $858k 21k 40.27
2018-09-30 $254k 3.7k 69.44
2018-06-30 $907k 12k 75.65
2018-03-31 $1.3M 25k 52.67